AP control of as the most efficacious tool for the prevention of cardiovascular complications in patients with type 2 diabetes mellitus
Эксперты прогнозируют значительный рост заболеваемости СД2 в ближайшие 10?15 лет. Неблагоприятный прогноз у этих больных определяется высоким риском развития кардио- и цереброваскулярных осложнений. Применение фиксированной комбинации периндоприла с индапамидом (нолипрел) у больных СД2 независимо от...
Enregistré dans:
Auteur principal: | Yury Alexandrovich Karpov |
---|---|
Format: | article |
Langue: | EN RU |
Publié: |
Endocrinology Research Centre
2009
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d36e35a4d5d64965bd734b54dd41ee0d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Tasks and objectives of the ADVANCE study. Design of the study. Rationale for the use of diabeton MB
par: Olga Mikhailovna Smirnova
Publié: (2009) -
Commentary on prevention of cardiovascular complications in diabetes mellitus as novel inidicationfor Diabeton MR
par: Olga Konstantinovna Vikulova
Publié: (2012) -
Specific features of pregnancy in patients with type 1 diabetes in the prepubertal period. Results of a 15-year long clinical observation
par: Lyubov' Leonidovna Bolotskaya, et autres
Publié: (2009) -
Epidemiological characteristics of diabetes mellitus and its complications in the Omsk region
par: Marina Lukmanovna Sayfullina, et autres
Publié: (2010) -
Age and sex-related variations in the time of manifestation of type 1 diabetes mellitus and its chronic complications in children
par: Oleg Avgustovich Dianov, et autres
Publié: (2010)